Prestige Consumer [PBH] vs Regencell Bioscience [RGC] Detailed Stock Comparison

Prestige Consumer

NYSE

Regencell Bioscience

NASDAQ

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Prestige Consumer wins in 8 metrics, Regencell Bioscience wins in 4 metrics, with 0 ties. Prestige Consumer appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Prestige Consumer	Regencell Bioscience	Better
P/E Ratio (TTM)	17.92	N/A	N/A
Price-to-Book Ratio	2.07	960.00	Prestige Consumer
Debt-to-Equity Ratio	56.91	0.01	Regencell Bioscience
PEG Ratio	16.12	N/A	N/A
EV/EBITDA	12.51	-1,664.45	Regencell Bioscience
Profit Margin (TTM)	18.86%	0.00%	Prestige Consumer
Operating Margin (TTM)	34.03%	0.00%	Prestige Consumer
EBITDA Margin (TTM)	34.03%	N/A	N/A
Return on Equity	12.30%	-47.77%	Prestige Consumer
Return on Assets (TTM)	6.50%	-30.65%	Prestige Consumer
Free Cash Flow (TTM)	$243.29M	$-4.01M	Prestige Consumer
1-Year Return	-5.19%	5,863.64%	Regencell Bioscience
Price-to-Sales Ratio (TTM)	3.33	N/A	N/A
Enterprise Value	$4.75B	$6.64B	Regencell Bioscience
EV/Revenue Ratio	4.17	N/A	N/A
Gross Profit Margin (TTM)	57.34%	N/A	N/A
Revenue per Share (TTM)	$23	N/A	N/A
Earnings per Share (Diluted)	$4.29	$-0.01	Prestige Consumer
Beta (Stock Volatility)	0.43	2.19	Prestige Consumer

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Prestige Consumer vs Regencell Bioscience Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Prestige Consumer	0.60%	-0.90%	-13.52%	-25.39%	-23.71%	-16.38%
Regencell Bioscience	3.31%	-6.08%	-4.23%	24.01%	13,020.00%	9,992.31%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Prestige Consumer	-5.19%	14.08%	74.66%	36.30%	774.70%	420.34%
Regencell Bioscience	5,863.64%	1,443.53%	4,585.71%	4,585.71%	4,585.71%	4,585.71%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Prestige Consumer (PBH): View Full Stock Overview

Regencell Bioscience (RGC): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Prestige Consumer vs Regencell Bioscience

Metric	PBH	RGC
Market Information
Market Cap i	$3.79B	$6.65B
Market Cap Category	Mid cap	Mid cap
10 Day Avg. Volume i	406,280	311,130
90 Day Avg. Volume i	411,937	1,546,083
Last Close	$64.99	$13.12
52 Week Range	$62.95 - $90.04	$0.09 - $83.60
% from 52W High	-27.82%	-84.31%
All-Time High	$90.04 (Mar 10, 2025)	$950.00 (May 30, 2025)
% from All-Time High	-27.82%	-98.62%
Growth Metrics
Quarterly Revenue Growth	0.07%	N/A
Quarterly Earnings Growth	0.01%	N/A
Financial Health
Profit Margin (TTM) i	0.19%	0.00%
Operating Margin (TTM) i	0.34%	0.00%
Return on Equity (TTM) i	0.12%	-0.48%
Debt to Equity (MRQ) i	56.91	0.01
Cash & Liquidity
Book Value per Share (MRQ)	$37.06	$0.01
Cash per Share (MRQ)	$1.98	N/A
Operating Cash Flow (TTM) i	$251.52M	$-3,881,392
Levered Free Cash Flow (TTM) i	$188.69M	$-4,301,837
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	$0.00	N/A

Valuation & Enterprise Metrics Analysis: Prestige Consumer vs Regencell Bioscience

Metric	PBH	RGC
Price Ratios
P/E Ratio (TTM) i	17.92	N/A
Forward P/E i	16.12	N/A
PEG Ratio i	16.12	N/A
Price to Sales (TTM) i	3.33	N/A
Price to Book (MRQ) i	2.07	960.00
Market Capitalization
Market Capitalization i	$3.79B	$6.65B
Enterprise Value i	$4.75B	$6.64B
Enterprise Value Metrics
Enterprise to Revenue i	4.17	N/A
Enterprise to EBITDA i	12.51	-1,664.45
Risk & Other Metrics
Beta i	0.43	2.19
Book Value per Share (MRQ) i	$37.06	$0.01

Financial Statements Comparison: Prestige Consumer vs Regencell Bioscience

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	PBH	RGC
Revenue/Sales i	$296.52M	N/A
Cost of Goods Sold i	$126.51M	N/A
Gross Profit i	$170.01M	N/A
Research & Development i	N/A	N/A
Operating Income (EBIT) i	$100.89M	N/A
EBITDA i	$91.97M	N/A
Pre-Tax Income i	$73.96M	N/A
Income Tax i	$23.83M	N/A
Net Income (Profit) i	$50.13M	N/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	PBH	RGC
Cash & Equivalents i	$97.88M	$2.96M
Total Current Assets i	$448.33M	$8.11M
Total Current Liabilities i	$106.62M	$193,578
Long-Term Debt i	$1.04B	$25,934
Total Shareholders Equity i	$1.83B	$8.22M
Retained Earnings i	$1.56B	$-21.62M
Property, Plant & Equipment i	$53.29M	$84,780

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	PBH	RGC
Operating Cash Flow i	$47.51M	N/A
Capital Expenditures i	$-3.48M	N/A
Free Cash Flow i	$58.37M	N/A
Debt Repayment i	$-2.64M	N/A
Common Stock Repurchase i	$-11.31M	N/A

Short Interest & Institutional Ownership Analysis

Metric	PBH	RGC
Shares Short i	1.51M	2.25M
Short Ratio i	3.44	1.15
Short % of Float i	0.04%	0.02%
Average Daily Volume (10 Day) i	406,280	311,130
Average Daily Volume (90 Day) i	411,937	1,546,083
Shares Outstanding i	49.51M	13.01M
Float Shares i	48.85M	18.43M
% Held by Insiders i	0.01%	0.96%
% Held by Institutions i	1.08%	0.00%

Dividend Analysis & Yield Comparison: Prestige Consumer vs Regencell Bioscience

Metric	PBH	RGC
Last 12-Month Dividend i	$0.00	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	$0.00	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	$0.00	N/A
Ex-Dividend Date	N/A	N/A

Prestige Consumer [PBH] vs Regencell Bioscience [RGC] Detailed Stock Comparison